Press "Enter" to skip to content

Puma Biotechnology, Inc. (PBYI) Q3 2025 Earnings Call Transcript

Mariann Ohanesian
Senior Director of Investor Relations

Thank you, Julian. Good afternoon, and welcome to Puma’s conference call to discuss our earnings results for the third quarter of 2025.

Joining me on the call today are Alan Auerbach, Chief Executive Officer, President, and Chairman of the Board of Puma Biotechnology; Maximo Nougues, Chief Financial Officer; Heather Blaber, Senior Vice President of Marketing; and Roger Storms, Senior Vice President of Sales.

After the close today, Puma issued a news release detailing earnings results for the third quarter of 2025. The webcast and presentation slides will be archived on our website and available for replay for the next 90 days.

Today’s conference call will include statements about Puma’s future expectations, plans, and prospects that constitute forward-looking statements for purposes of federal securities laws. Such statements are subject to risks and uncertainties, and actual events and results may differ from those expressed in these forward-looking statements.

For a full discussion of these risks and uncertainties, please review our periodic and current reports filed with the SEC.
https://seekingalpha.com/article/4840492-puma-biotechnology-inc-pbyi-q3-2025-earnings-call-transcript?source=feed_all_articles

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *